MSB 10.4% $1.49 mesoblast limited

If the science is false, why isn't it being challenged?, page-80

  1. 20 Posts.
    lightbulb Created with Sketch. 19
    They did not come up with the critique. The author, an accountant I believe, but I don't have time to check that, did.
    I can only wonder what, as a non holder of the shares, your agenda can be.
    Is it really to save to save all of us poor investors from ourselves?. Or do you have, as others have suggested, other motives?.
    I, quite honestly, do not have the time to explore the veracity, or otherwise of the E BioMedicine Journal.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.